Transapical transcatheter treatment of a stenosed aortic valve bioprosthesis using the Edwards SAPIEN Transcatheter Heart Valve.
Transcatheter transapical or transfemoral aortic valve replacement has emerged as an alternative therapy of severe, symptomatic valvular aortic stenosis in surgically nonamenable patients. We report a transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis (Sorin Group, Vancouver, British Columbia, Canada) in an 82-year-old woman using a 23-mm Edwards SAPIEN Transcatheter Heart Valve (Edwards Lifesciences, Irvine, CA).
Klaaborg
Kaj-Erik
KE
Department of Thoracic and Cardiovascular Surgery, Aarhus University Hospital, Skejby, Denmark.
Egeblad
Henrik
H
Jakobsen
Carl-Johan
CJ
Terp
Kim
K
Lindskov
Christian
C
Andersen
Henning Rud
HR
Thuesen
Leif
L
D000369:Aged, 80 and over; D001024:Aortic Valve Stenosis / Q000601:surgery*; D001705:Bioprosthesis; D006328:Cardiac Catheterization; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D011183:Postoperative Complications / Q000601:surgery*; D011474:Prosthesis Design